Abiraterone
The serum concentration of Frovatriptan can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aceprometazine.
Advertisement
Acetophenazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Acetophenazine.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Frovatriptan.
Amisulpride
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Amisulpride.
Advertisement
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Frovatriptan.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Frovatriptan.
Amphetamine
The serum concentration of Frovatriptan can be increased when it is combined with Amphetamine.
Advertisement
Aripiprazole
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aripiprazole.
Asenapine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Asenapine.
Azithromycin
The metabolism of Frovatriptan can be decreased when combined with Azithromycin.
Benperidol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Benperidol.
Bortezomib
The metabolism of Frovatriptan can be decreased when combined with Bortezomib.
Brexpiprazole
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Brexpiprazole.
Bromocriptine
Bromocriptine may increase the vasoconstricting activities of Frovatriptan.
Bromperidol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Bromperidol.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Frovatriptan.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Frovatriptan.
Caffeine
The metabolism of Frovatriptan can be decreased when combined with Caffeine.
Cariprazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Cariprazine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Chlorprothixene.
Citalopram
The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.
Clomipramine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Clomipramine.
Clotrimazole
The metabolism of Frovatriptan can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Clozapine.
Cyamemazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Cyamemazine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Frovatriptan.
Cyproterone Acetate
The serum concentration of Frovatriptan can be decreased when it is combined with Cyproterone acetate.
Dapiprazole
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Dapiprazole.
Deferasirox
The serum concentration of Frovatriptan can be increased when it is combined with Deferasirox.
Desipramine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Desipramine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Desvenlafaxine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Frovatriptan.
Dihydroergotamine
Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.
Dolasetron
Dolasetron may increase the serotonergic activities of Frovatriptan.
Dothiepin
The metabolism of Frovatriptan can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Doxepin.
Droperidol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Droperidol.
Droxidopa
Frovatriptan may increase the hypertensive activities of Droxidopa.
Duloxetine
The risk or severity of adverse effects can be increased when Duloxetine is combined with Frovatriptan.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Frovatriptan.
ergoloid mesylates, USP
Ergoloid mesylate may increase the vasoconstricting activities of Frovatriptan.
Ergonovine
Ergonovine may increase the vasoconstricting activities of Frovatriptan.
Ergotamine
Ergotamine may increase the vasoconstricting activities of Frovatriptan.
Escitalopram
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Frovatriptan.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.
Flupenthixol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fluphenazine.
Fluspirilene
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fluspirilene.
Fluvoxamine
The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.
Furazolidone
The metabolism of Frovatriptan can be decreased when combined with Furazolidone.
Granisetron
Granisetron may increase the serotonergic activities of Frovatriptan.
Haloperidol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Haloperidol.
Iloperidone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Frovatriptan.
Iproniazid
The metabolism of Frovatriptan can be decreased when combined with Iproniazid.
Isocarboxazid
The serum concentration of Frovatriptan can be increased when it is combined with Isocarboxazid.
Levomilnacipran
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Levomilnacipran.
Lidocaine
The metabolism of Frovatriptan can be decreased when combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Frovatriptan.
Lithium
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lithium.
Lorcaserin
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lorcaserin.
Loxapine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Loxapine.
Lurasidone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lurasidone.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Frovatriptan.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Frovatriptan.
Mesoridazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Mesoridazine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Frovatriptan.
Methotrimeprazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Methotrimeprazine.
Methylene blue
The serum concentration of Frovatriptan can be increased when it is combined with Methylene blue.
Methylergonovine
Methylergometrine may increase the vasoconstricting activities of Frovatriptan.
Metoclopramide
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Metoclopramide.
Metylperon
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Melperone.
Mexiletine
The metabolism of Frovatriptan can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Frovatriptan can be decreased when combined with Midostaurin.
Milnacipran
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Milnacipran.
Minaprine
The metabolism of Frovatriptan can be decreased when combined with Minaprine.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Frovatriptan.
Moclobemide
The serum concentration of Frovatriptan can be increased when it is combined with Moclobemide.
Molindone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Molindone.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Frovatriptan.
Nefazodone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Nefazodone.
Nevirapine
The metabolism of Frovatriptan can be decreased when combined with Nevirapine.
Nialamide
The metabolism of Frovatriptan can be decreased when combined with Nialamide.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Frovatriptan.
Olanzapine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Olanzapine.
Ondansetron
Ondansetron may increase the serotonergic activities of Frovatriptan.
Osimertinib
The serum concentration of Frovatriptan can be decreased when it is combined with Osimertinib.
Paliperidone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Frovatriptan.
Pargyline
The metabolism of Frovatriptan can be decreased when combined with Pargyline.
Paroxetine
The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.
Peginterferon Alfa-2b
The serum concentration of Frovatriptan can be increased when it is combined with Peginterferon alfa-2b.
Perazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Perazine.
Periciazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Propericiazine.
Perphenazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Perphenazine.
Phenelzine
The serum concentration of Frovatriptan can be increased when it is combined with Phenelzine.
Pimozide
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Pipotiazine.
Procarbazine
The serum concentration of Frovatriptan can be increased when it is combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Prochlorperazine.
Promazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Promethazine.
Prothipendyl
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Frovatriptan.
Quetiapine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Quetiapine.
Rasagiline
The serum concentration of Frovatriptan can be increased when it is combined with Rasagiline.
Remoxipride
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Reserpine.
Risperidone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Risperidone.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Frovatriptan.
Ropinirole
The metabolism of Frovatriptan can be decreased when combined with Ropinirole.
Rucaparib
The metabolism of Frovatriptan can be decreased when combined with Rucaparib.
Selegiline
The serum concentration of Frovatriptan can be increased when it is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.
Simeprevir
The metabolism of Frovatriptan can be decreased when combined with Simeprevir.
Sulpiride
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Frovatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Frovatriptan.
Tapentadol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Tapentadol.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Frovatriptan.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Frovatriptan.
Tenofovir Disoproxil
The metabolism of Frovatriptan can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Frovatriptan can be decreased when it is combined with Teriflunomide.
Theophylline
The metabolism of Frovatriptan can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Frovatriptan can be decreased when combined with Theophylline.
Thioproperazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Thioproperazine.
Thioridazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Thiothixene.
Tiapride
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Tiapride.
Ticlopidine
The metabolism of Frovatriptan can be decreased when combined with Ticlopidine.
Toloxatone
The metabolism of Frovatriptan can be decreased when combined with Toloxatone.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Frovatriptan.
Tranylcypromine
The serum concentration of Frovatriptan can be increased when it is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Frovatriptan.
Trifluoperazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Frovatriptan.
Tropisetron
Tropisetron may increase the serotonergic activities of Frovatriptan.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Frovatriptan.
Vemurafenib
The serum concentration of Frovatriptan can be increased when it is combined with Vemurafenib.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Frovatriptan.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Frovatriptan.
Ziprasidone
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Frovatriptan.
Zotepine
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Zuclopenthixol.
